Skip to main content

Polyarticular Juvenile Idiopathic Arthritis News

Related terms: Polyarticular JIA

FDA Expands Pediatric Indication for Rinvoq

FRIDAY, June 21, 2024 – The U.S. Food and Drug Administration has expanded indications for Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular...

FDA Approves Tyenne (tocilizumab-aazg), a Biosimilar to Actemra

March 7, 2024 – Fresenius Kabi, a global health care company that specializes in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Juvenile Idiopathic Arthritis

Related drug support groups

naproxen, methotrexate, Humira, Enbrel, Xeljanz, adalimumab, etanercept, Actemra